Your browser doesn't support javascript.
loading
A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study).
Shimomura, Akihiko; Tamura, Kenji; Tanaka, Kiyo; Mizutani, Tomonori; Sasaki, Keita; Sekino, Yuta; Sawaki, Masataka; Shien, Tadahiko; Shibata, Taro; Iwata, Hiroji.
Afiliación
  • Shimomura A; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Tamura K; Department of Medical Oncology, Shimane University Hospital, Shimane, Japan.
  • Tanaka K; Department of Breast and Endocrine Surgery, Toranomon Hospital, Tokyo, Japan.
  • Mizutani T; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
  • Sasaki K; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Sekino Y; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Sawaki M; Department of Breast Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
  • Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama Japan.
  • Shibata T; Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
  • Iwata H; Department of Breast Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
Jpn J Clin Oncol ; 51(9): 1471-1474, 2021 Aug 30.
Article en En | MEDLINE | ID: mdl-34215870

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Ado-Trastuzumab Emtansina Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans País/Región como asunto: Asia Idioma: En Revista: Jpn J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Ado-Trastuzumab Emtansina Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans País/Región como asunto: Asia Idioma: En Revista: Jpn J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Japón